Cerapedics has received the US patent 8,048,443 which protects the manufacture method of i-Factor Biologic Bone Graft in lyophilized forms.

i- Factor biologic bone graft utilizes the company’s proprietary anorganic bone mineral (ABM) and synthetic small peptide (P-15) technologies used in orthopedic surgical, spine and trauma. procedures.

i-FACTOR biologic bone graft is currently being evaluated by the US FDA as part of an Investigational Device Exemption (IDE) clinical study in the cervical spine.